Healthcare Financial Management Association (HFMA) Announces Matthew E. Cox as National Chair Along with New Officers, Board Members

Why It Matters

Cox’s leadership and the board’s fresh expertise position HFMA to steer the industry through mounting financial and operational challenges, fostering coordinated solutions that can improve sustainability and patient access.

Key Takeaways

• Matt Cox, CFO of Corewell Health, becomes HFMA National Chair.
• Board adds venture-capital leader Marcus Whitney as chair‑elect.
• Michele Napier oversees $7 B patient revenue at Orlando Health.
• New members bring expertise in finance, innovation, and payer‑provider tech.
• HFMA aims to boost collaboration on affordability, workforce and digital change.

Pulse Analysis

The Healthcare Financial Management Association, with more than 145,000 members across hospitals, health systems, physician practices and payers, serves as a central hub for finance professionals navigating an increasingly complex regulatory and market environment. By providing education, tools, and thought leadership, HFMA influences how the industry allocates resources, manages risk, and implements cost‑containment strategies. Its annual conference and collaborative platforms have become essential venues for sharing best practices and shaping policy direction.

Matthew E. Cox’s appointment as National Chair signals a strategic shift toward deeper integration of financial stewardship with broader health equity goals. As Corewell Health’s CFO, Cox has overseen initiatives that balance cost control with expanding access, a perspective that aligns with HFMA’s focus on affordability, workforce transformation, and digital innovation. His emphasis on cross‑organizational collaboration is likely to accelerate the adoption of data‑driven budgeting, value‑based payment models, and technology‑enabled revenue cycle improvements, helping members navigate pressures from insurers, regulators, and an evolving patient population.

The newly elected board members broaden HFMA’s expertise, blending venture‑capital insight, large‑scale revenue management, and cutting‑edge health‑tech entrepreneurship. Marcus Whitney’s venture background, Michele Napier’s oversight of a $7 billion revenue portfolio, and Jeremy Friese’s work on AI‑powered prior authorization collectively position HFMA to champion innovative financing solutions and payer‑provider integration. This diversified leadership is expected to produce actionable guidance on emerging trends, from telehealth reimbursement to supply‑chain resilience, reinforcing HFMA’s role as the industry’s go‑to resource for sustainable financial performance.